Ocular Therapeutix, Inc (OCUL): EPS (Basic)
-$1.42
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.42 | n/m | 2026-02-05, From 2025-01-01 |
| 2024-12-31 | -$1.22 | n/m | 2026-02-05, From 2024-01-01 |
| 2023-12-31 | -$1.01 | n/m | 2026-02-05, From 2023-01-01 |
| 2022-12-31 | -$0.92 | n/m | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | -$0.09 | n/m | 2024-03-11, From 2021-01-01 |
| 2020-12-31 | -$2.56 | n/m | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | -$1.91 | n/a | 2022-02-28, From 2019-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | -$1.42 | n/m |
| Q32 Bio Inc. (QTTB) | 2025-12-31 | $2.42 | n/m |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | -$7.12 | n/m |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | -$0.14 | n/m |
| Nektar Therapeutics (NKTR) | 2025-12-31 | -$9.73 | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$0.75 | n/m |
| Aytu Biopharma, Inc (AYTU) | 2026-06-30 | -$1.16 | n/m |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | -$2.05 | n/m |
| Septerna, Inc. (SEPN) | 2025-12-31 | -$1.10 | n/m |
Compare OCUL, QTTB, AGIO, LXRX side by side · Screen every company in Pharmaceutical Preparations ↗